- Medical Records
- Cilt: 5 Sayı: 3
- Second Allogeneic Stem Cell Transplantation in Acute Leukemia with Post-Transplantation Relapse
Second Allogeneic Stem Cell Transplantation in Acute Leukemia with Post-Transplantation Relapse
Authors : Zeynep Tuğba Güven, Serhat Çelik, Bülent Eser, Mustafa Çetin, Ali Ünal, Leylagül Kaynar
Pages : 455-9
Doi:10.37990/medr.1259944
View : 53 | Download : 95
Publication Date : 2023-09-18
Article Type : Research
Abstract :Aim: It is known that the prognosis of acute leukemia patients who relapse after the first allogeneic stem cell transplantation (ASCT) is dismal. Our goal was to assess the value of a second allogeneic stem cell transplant in acute leukemia patients who experienced post-transplant recurrence. Material and Methods: We retrospectively reviewed data from 29 patients with relapsing acute leukemia who underwent a second ASCT. Nineteen patients with acute myeloid leukemia and ten patients with acute lymphoblastic leukemia were included in the study. Results: Ten AML patients and 10 ALL patients were included in the study. Most patients (62%) were in remission before the second transplantation. The median time between the first and second ASCT was 11.9 months (3.1-42 months). Complete remission (CR) was achieved after the second ASCT in 21 (72%) patients, and 11 (52%) patients relapsed after the second ASCT. During this analysis, six patients (21%) were alive and in remission. Relapse of the disease was the leading cause of mortality. After the second ASCT, overall survival (OS) was 6.34 months, and leukemia-free survival (LFS) was 13.8 months. Conclusion: For patients with acute leukemia who relapsed after the first ASCT, a second ASCT is a good option and can keep patients alive.Keywords : Post transplantation relapse, second transplantation, acute leukemia